Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
PhaseBio Pharmaceuticals Inc (PHAS)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -1753.6% | -844.1% | -1215.4% | | | |
ROIC (including intangibles) | 6627.4% | -604.6% | -654.7% | -4183.6% | 252.9% | 3707.7% |
ROE | 116.8% | 336.7% | -66.3% | -38.6% | 109.7% | -398.4% |
ROA | -179.5% | -168.5% | -48.2% | -31.2% | -60.6% | -230.8% |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | 0.0 | 0.0 | 0.0 | | 0.0 |
Days payables outstanding | | | | | | 16.6 |
Cash conversion cycle | | | | | | -16.6 |
|